ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Maastricht UMC+ at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Maastricht UMC+ takes part in 8 sessions at ESMO 2026 in Madrid. Its sessions cover treatment and outcomes in breast and lung cancer, as well as brain tumours and supportive care. They examine how treatment patterns relate to outcomes in HER2-positive metastatic breast cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
Maastricht UMC+ Maastricht, Netherlands | |
Academic hospital and university medical centre of Maastricht University in Maastricht, the Netherlands. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Chair Fri Oct 23 13:30–15:00 Rapid oral: CNS tumours Sarcoma, CNS, head & neck and rare cancers Abstract Fri Oct 23 14:42–14:52 Invited Discussant 702RO and 703RO Sarcoma, CNS, head & neck and rare cancers Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Satellite Sun Oct 25 13:00–14:30 Johnson & Johnson - Transforming the Treatment Journey in EGFR- Mutant NSCLC Lung & thoracic cancers Satellite Sun Oct 25 13:00–13:05 Welcome and introductions Lung & thoracic cancers Satellite Sun Oct 25 13:15–13:27 Chair Mon Oct 26 14:45–16:00 Modern management of leptomeningeal metastases Sarcoma, CNS, head & neck and rare cancers Talk Mon Oct 26 14:45–14:50 Presentation of case/condition Sarcoma, CNS, head & neck and rare cancers |
Find decision makers at Maastricht UMC+
Tell us what you sell and we’ll find the people at Maastricht UMC+ most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction